MyChesCo on MSN3h
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences
Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two prominent ...
lupus.bmj7h
Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
dermatologyadvisor8h
Patients With CLE With Certain Characteristics Have Lower Treatment Response
Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.
emjreviews.com1d
Women on Menopausal Hormone Therapy Face Higher Risk of Lupus and Scleroderma
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
Healthline4d
Understanding the Link Between Lupus and Depression and How to Get Help
People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...
rheumatologyadvisor4d
Digital Therapeutics Set to Transform Pain Management in Rheumatic Disease
Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.